Form 4: Haemonetics Director Receives Stock Grant
Insider Transaction (Form 4)
Lloyd Emerson Johnson, a Director of Haemonetics Corp, received 2,538 shares of common stock on July 24, 2026.
Summary
- Grant/award: acquired 2,538 Common Stock on July 24, 2026; holds 15,471 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Lloyd Emerson Johnson — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-24 | Grant/award | Common Stock | 2,538 | — | — | 15,471 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-24 | Grant/award (2,538 shares) |
Keywords
insider transaction, Form 4, HAE, HAEMONETICS CORP, neutral, Lloyd Emerson Johnson
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.